Complete resolution of psoriasis vulgaris after excision of thyroid cancer

International Journal of Dermatology

Volumn 36, Issue 4, 1997, Pages 280-282

  Kano, Yoko ^a   Chiba, Masako ^a   Yagita, Akikuni ^a   Shiohara, Tetsuo ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; LEVOTHYROXINE SODIUM;

ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; FEMALE; HUMAN; HYPERKERATOSIS; LYMPHOCYTIC INFILTRATION; PARAKERATOSIS; PSORIASIS VULGARIS; REMISSION; SKIN BIOPSY; THYROID CARCINOMA;

EID: 0030979353     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1997.tb03044.x     Document Type: Article

References (7)

1. Elias AN, Goodman MM, Liem WH, Barr RJ. Propylthiouracil in psoriasis: results of an open trial. J Am Acad Dermatol 1993; 29: 78-81.
2. Hoath SB, Lakshmanan J, Scott SM, Fisher DA. Effect of thyroid hormones on epidermal growth factor concentration in neonatal mouse skin. Endocrinology 1983; 112: 308-314.
3. Ellis DL, Kafka SP, Chow JC, et al. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alfa-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med 1987; 317: 1581-1587.
4. Nikoloff BJ. The cytokine network in psoriasis. Arch Dermatol 1991; 127: 871-884.
5. Sagawa Y, Shiohara T, Imanishi K, Nagashima M. Is sustained production of tumor necrosis factor-α relevant to the development of pustular psoriasis? Dermatology 1993; 187: 81-83.
6. Hughes BR, Cotterill JA. The relationship of psoriasis to malignancy: a clinical report. Clin Exp Dermatol 1993; 18: 41-44.
7. Takematsu H, Ozawa H, Yoshimura T, et al. Systemic TNF administration in psoriatic patients: a promising therapeutic modality for severe psoriasis. Br J Dermatol 1991; 114: 209-210.